JP Patent

JP4846965B2 — 真核細胞におけるエキソンスキッピングの誘導

Assigned to アカデミスツィーケンホイスライデン · Expires 2011-12-28 · 14y expired

What this patent protects

Patent listed against Amondys 45.

Drugs covered by this patent

Amondys 45 (CASIMERSEN) · Sarepta

Patent Metadata

Patent number: JP4846965B2
Jurisdiction: JP
Classification: —
Expires: 2011-12-28
Drug substance claim: No
Drug product claim: No
Assignee: アカデミスツィーケンホイスライデン
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.